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Abstract
BMP7 is expressed in ureteric buds and cap mesenchyme of the fetal kidney,
mediating branching morphogenesis and survival and priming of metanephric
mesenchyme. Although dose-dependent effects of BMP7 in collecting duct
cells have been reported, studies in metanephric mesenchymal cells are lack-
ing. We examined the effects of BMP7 on MAP kinase activation, prolifera-
tion, and expression of cadherins in a metanephric mesenchymal cell line MS7
by thymidine incorporation, immunoblot analysis, and quantitative real-time
PCR. The levels of phosphorylated ERK (P-ERK) and phosphorylated p38
(P-p38) were not altered at 10 min, 1 h, and 6 h with low-dose BMP7 (0.25
nmol/L), but were increased at 24 h. At 24 h, P-ERK was increased with low-
dose BMP7, but not by intermediate- (1 nmol/L) or high-dose (10 nmol/L)
BMP7, whereas p38 was activated by intermediate-dose BMP7. Cell prolifera-
tion of MS7 was significantly increased by low- and intermediate-dose BMP7
and decreased by high-dose BMP7. A p38 inhibitor SB203580 5 lmol/L or a
MEK inhibitor PD98059 5 lmol/L abolished BMP7-stimulated proliferation.
Expression of cadherin-11, an adhesion molecule known to promote cell
migration and compaction, was upregulated by intermediate-dose BMP7.
BMP7-induced cadherin-11 expression was inhibited by cotreatment with
SB203580 and PD98059. Finally, in metanephroi cultured with siRNA for cad-
herin-11, the number and thickness of cap mesenchyme were reduced. In con-
clusion, BMP7 exerts differential effects depending on the concentration; it
may expand mesenchymal cells in the stroma where BMP7 concentration is
low and may upregulate cadherin-11 promoting condensation around the tip
of ureteric buds.
Introduction
BMP7 (bone morphogenetic protein 7) is a morphogen
expressed in ureteric buds and cap mesenchyme mediat-
ing branching morphogenesis and survival/priming of
metanephric mesenchyme. Morphogens are diffusible fac-
tors that influence developmental patterns by forming
gradients, which specify different fates for cells (Bier and
De Robertis 2015). Thus, BMPs exert their actions in a
dose-dependent fashion. While dose-dependent effects of
BMP7 in collecting duct cells have been reported, studies
in metanephric mesenchymal cells are lacking (Piscione
et al. 2001).
BMP7 is one of the major BMPs important in kidney
development. BMP7-deficient kidneys are small and have
disorganized architecture characterized by apoptosis of
metanephric mesenchyme (Dudley and Robertson 1997).
These features are similar to metanephroi cultured with
an inhibitor of p38 mitogen-activated protein kinase
(p38) as previously reported (Hida et al. 2002). BMP7
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has been reported to be necessary for the maintenance of
nephron progenitor cells through another member of
MAP kinase c-Jun N-terminal kinase (JNK) (Blank et al.
2009). Both JNK and p38 are activated by BMP7 via
TAK1. Extracellular signal-regulated kinase (ERK) of
MAP kinase is also shown to be activated by BMP7,
although the signaling pathways are not well defined (Gri-
jelmo et al. 2007). We previously showed that blockade of
ERK activation inhibited nephrogenesis in a similar man-
ner to p38 inhibition, although the extent was less and
the metanephros size was not affected (Hida et al. 2002).
Recently, it has been shown that BMP7 primes nephron
progenitors for differentiation (Brown et al. 2013). Thus,
BMP7 promotes transition of Cited1+ nephron progeni-
tor cells to Six2-expressing cells that are inducible by
WNT/b-catenin signaling. This action of BMP7 is
reported to be mediated by Smad pathway (Brown et al.
2013).
Adhesion molecule cadherins are important in the
development stimulating cell migration, compaction, and
establishing polarity. Metanephric mesenchyme expresses
cadherin 11 (CDH11), which is downregulated during
epithelialization. R-cadherin and cadherin 6 becomes
expressed coinciding with the formation of the renal vesi-
cle. E-cadherin is not seen during the pretubular aggre-
gate stage (Marciano 2016). BMP7 is reported to
upregulate or induce E-cadherin in renal fibroblasts or
cultured metanephric mesenchymal cells, respectively
(Zeisberg et al. 2005; Gai et al. 2009), but its effect on
other cadherins in the kidney is unknown.
In the present study, we investigated the dose-depen-
dent effects of BMP7 on proliferation, MAP kinase activa-




BMP7 was from R&D systems (Minneapolis, MI). Anti-
bodies against phosphorylated p38 (P-p38) and phospho-
rylated ERK (P-ERK) were from Cell Signaling
Technology (Beverly, MA). Anti-p38 antibody (C-20) was
from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-
ERK antibody (Erk1/2-CT, rabbit polyclonal IgG) was
from Upstate Biotechnology (Lake Placid, NY). Mouse
and rabbit anti-cadherin-11 antibodies were from Zymed
Laboratories (South San Francisco, CA). Anti-uvomoru-
lin/E-cadherin antibody was from Sigma (Saint Louis,
MO), and anti-K-cadherin antibody (cadherin 6, sc-
31024, sc-59974) was from Santa Cruz Biotechnology
(Santa Cruz, CA). Horseradish peroxidase-conjugated
anti-mouse IgG and anti-rabbit IgG were from Amersham
(Buckinghamshire, UK). A p38 inhibitor SB203580 and a
MEK inhibitor PD98059 were from Carbiochem-Novabio-
chem (La Jolla, CA). DMEM, FBS, penicillin, strepto-
mycin, Hanks’ balanced salt solution, and trypsin-EDTA
were from Gibco Laboratories (Grand Island, NY).
Cell line
An immortalized metanephric mesenchymal cell line MS7
was generated from the metanephroi of embryonic day
11.5 homozygous mouse transgenic for H-2Kb-tsA (Take-
mura et al. 2001). MS7 is positive for vimentin and nega-
tive for cytokeratin and DBA. Cells were grown in
DMEM containing 10% FBS, penicillin 100 U/mL, and
streptomycin 100 mg/mL. The cultures were maintained
at 37°C in a humidified atmosphere of 95% O2–5% CO2.
Cells were grown to 80% confluence and serum
deprived for 48 h. Cells were then treated with BMP7,
SB203580, PD98059, or vehicle for various times.
[3H]-Thymidine incorporation
Cells were grown in a 24-well dish and serum deprived
for 48 h. Cells were then treated with low- (0.25 nmol/L),
intermediate- (1 nmol/L), or high-dose (10 nmol/L)
BMP7 or vehicle. In other experiments, cells were treated
with 5 lmol/L SB203580 or 5 lmol/L PD98059 in addi-
tion to 1 nmol/L BMP7. Cells were then pulsed with
1 lCi [3H]-thymidine. After incubation for 18 h, cells
were washed with ice-cold PBS and 5% trichloroacetic
acid, solubilized in 0.5 N NaOH, and counted by a liquid
scintillation counter.
Quantitative real-time PCR (qPCR)
Total RNA was extracted from the cells using TRIzol
(Invitrogen, Carlsbad, CA) and reverse transcribed into
cDNA. qPCR was performed using SYBER Premix Ex Taq
II (Takara Bio, Shiga, Japan). The primers used are shown
in Table 1.
Immunoblot analysis
Cells were lysed in solubilization buffer containing
20 mmol/L HEPES (pH 7.2), 1% Triton X-100, 10% glyc-
erol, 20 mmol/L sodium fluoride, 1 mmol/L sodium
orthovanadate, 1 mmol/L phenylmethanesulfonyl fluoride,
10 lg/mL aprotinin, and 10 lg/mL leupeptin. Insoluble
material was removed by centrifugation (10,500g,
10 min). Lysates were resolved by SDS-PAGE and trans-
ferred to PVDF membranes (Immobilon, Millipore, Bed-
ford, MA). Nonspecific binding sites were blocked in
Tris-buffered saline (TBS) (10 mmol/L Tris・HCl, pH 7.4,
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0.15 mol/L NaCl) containing 0.1% Tween 20 and 5%
skim milk or BSA overnight at 4°C or for 1 h at 25°C.
Antibodies were added to TBS containing 0.1% Tween 20
with 5% BSA and incubated with mixing for 24 h at 4°C.
The following dilution of antibodies were used: P-p38 at
1:2000, P-ERK at 1:1000, p38 at 1:5000, ERK at 1:1000,
CDH11 at 1:125. Bound antibodies were detected using
the ECL western blotting system (Amersham, Arlington
Heights, IL). All experiments were repeated on at least
three separate occasions. Bands were quantitatively ana-
lyzed by ImageJ software.
Organ culture
Approval was obtained from the Animal Experiment
Committee of Keio University. Culture of embryonic kid-
neys was performed using low-volume system (Sebinger
et al. 2010). Embryonic day 13 metanephroi were isolated
from ICR mice and cultured in sterilized silicone rings on
coverslips with 85 lL culture medium. Transfection of
siRNA was performed with Lipofectamine 2000 (Invitro-
gen, Carlsbad, CA) (Davies and Unbekandt 2012).
Sequences are shown in Table 2. Next day, the medium
was changed to 10% FBS DMEM and cultured for 2 more
days. Metanephroi were then fixed with cold methanol.
In other sets of experiments, embryonic day 12 metane-
phroi were transfected with siRNA for 24 h and further
cultured in 10% FBS DMEM for 24 h. Ureteric buds and
cap mesenchyme were visualized by incubation with anti-
pancytokeratin antibody (Sigma, St. Louis, MO) and anti-
Six 2 antibody (proteintech, Rosemont, IL), each followed
by Cy3-conjugated anti-mouse antibody or FITC-conju-
gated anti-rabbit antibody. In some experiments, metane-
phroi were stained with rabbit anti-CDH11 and anti-
pancytokeratin antibody. Samples were washed three
times with PBT, mounted in SlowFade, and viewed under
a confocal imaging system (Leica TCS-SP5, Leica
Microsystems, Tokyo, Japan).
Statistical analysis
The results are expressed as mean  SE. Statistical analy-
sis was performed with ANOVA. Statistical significance
was determined as P < 0.05.
Results
Dose-dependent effects of BMP7 on ERK and
p38 activation
The level of phosphorylated ERK (P-ERK) or phosphory-
lated p38 (P-p38) in MS7 was not altered by low-dose
BMP7 (0.25 nmol/L) at 10 min, 1 h, and 6 h, but was
increased at 24 h (Fig. 1). At 24 h, P-ERK and P-p38
were increased by low-dose and intermediate-dose
(1 nmol/L) BMP7, respectively (Fig. 2).
Dose-dependent effects of BMP7 on cell
proliferation
MS7 cell proliferation assessed by thymidine incorpora-
tion was increased by low- and intermediate-dose BMP7,
but inhibited by high-dose (10 nmol/L) BMP7 (Fig. 3A).
A p38 inhibitor SB203580 5 lmol/L or a MEK inhibitor
PD98059 5 lmol/L abolished low-dose BMP7-stimulated
proliferation (Fig. 3B).
Dose-dependent effects of BMP7 on
cadherin-11 expression
Cadherin 6 or E-cadherin, assessed by qPCR and/or
immunoblot, was not detected in basal state nor induced
Table 1. Sequences of oligonucleotide primers used in this study.




Table 2. Sequences of siRNA for cadherin-11.
Sense Antisense
siRNA a CAAUUGAUCGUCAUACUGATT UCAGUAUGACGAUCAAUUGTT
siRNA b CAAGUUAUAUCCAUGAAGUTT ACUUCAUGGAUAUAACUUGTT
Irrelevant siRNA UCUUAAUCGCGUAUAAGGCTT GCCUUAUACGCGAUUAAGATT
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by any concentrations of BMP7 in MS7 (data not shown).
The assays were validated with positive controls (fetal
mouse kidney). On the other hand, CDH11 assessed by
qPCR and immunoblot was present in MS7 and increased
by incubation with intermediate-dose BMP7 for 24 h
(Fig. 4A–C). BMP7-induced upregulation of CDH11 was
not affected by SB203580 5 lmol/L or PD98059 5 lmol/L
alone, but was reversed by cotreatment with both
(Fig. 4D and E).
Effect of siRNA for cadherin-11 in organ
culture
Embryonic day 13 mouse metanephroi were transfected
with two different siRNAs for CDH11 and further cul-
tured for 2 days. Cap mesenchyme marked by Six2 was
well observed around ureteric tips in control metanephroi
and those transfected with irrelevant siRNA (Fig. 5A). On
the other hand, in metanephroi transfected with siRNAs,
Six2-positive cells were diffusely distributed and conden-
sation around the ureteric tips was hardly observed. In
metanephroi transfected with irrelevant siRNA, strong
CDH11 expression was observed around ureteric tips
(Fig. 5B). On the other hand, CDH11 expression was dif-
fused and reduced in metanephroi transfected with siRNA
a or b. To accurately count the number of ureteric bud
tips, embryonic day 12 metanephroi were transfected and
further cultured for 1 day (Fig. 6). The number of ure-
teric tips of transfected metanephroi was significantly less
compared with those of nontransfected metanephroi. Kid-
ney surface area of transfected metanephroi tended to be
smaller, although the statistical significance was not
achieved.
Discussion
The present study showed that BMP7 increased prolifera-
tion and CDH11 expression in dose-dependent fashion in
a metanephric mesenchymal cell line. These effects of
BMP7 on proliferation and CDH11 expression corre-
spond to the differential activation of ERK and p38, and
were suppressed by the inhibition of either or both,
respectively.
We used the concentrations of BMP7, which previous
studies have shown to be effective in collecting duct cells
(Piscione et al. 1997, 2001; Hu et al. 2004). In the ure-
teric bud, which differentiates into the collecting duct, a
concentration gradient of BMP7 is considered to exist
with higher concentration at the tip and lower level in
the trunk. The low (0.25 nmol/L) to high (28 nmol/L)
concentrations were determined as those which exert
effects on the proliferation of cultured collecting duct
cells similar to those observed in tissue explants (Piscione
et al. 2001).
Figure 1. Time course of ERK and p38 activation by BMP7 in metanephric mesenchymal cells. Cells were incubated with low concentration of
BMP7 (0.25 nmol/L) for 10 min, 1, 6, and 24 h, and lysed for immunoblot analysis. BMP7 increased phosphorylated ERK (P-ERK) and
phosphorylated p38 (P-p38) at 24 h. Representative immunoblots (A) and quantitative analysis (B; n = 3 for both P-ERK/ERK and P-p38/p38).
*P < 0.05 versus 0 min.
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The effect of BMP7 on metanephric mesenchyme has
previously been investigated only in organ culture. Thus,
0.25 nmol/L BMP7 increased kidney surface area, while
1 nmol/L BMP7 exerted a negative effect on explant
growth (Piscione et al. 1997). These results are in accord
with the present study in which BMP7 exerts contradic-
tory effects on proliferation depending on the concentra-
tion. In the stroma or cap mesenchyme distant from the
tip, BMP7 concentration is considered to be lower, and
metanephric mesenchymal cells proliferate. Near the tip of
ureteric bud, on the other hand, the growth may be less
or even inhibited and cells may be primed for differentia-
tion. Recently, Tanigawa et al. (2016) reported that high
concentrations of BMP7 (more than 1.6 nmol/L) reduced
the percentage of nephron progenitor Six2-positive cells,
while lower concentrations (0.3 nmol/L) were optimal for
Figure 2. Dose dependency of BMP7 on the activation of ERK and p38 in metanephric mesenchymal cells. Cells were incubated with low-dose
(0.25 nmol/L), intermediated-dose (1 nmol/L), or high-dose (10 nmol/L) BMP7 for 24 h, and lysed for immunoblot analysis. Representative
immunoblots (A) and quantitative analysis (B; n = 5 for P-ERK and n = 6 for P-p38). *P < 0.05 versus 0 nmol/L.
Figure 3. Effects of BMP7 on cell proliferation. (A) Dose dependency. Cells were incubated with various concentrations of BMP7 and [3H]-
thymidine for 24 h (n = 4). (B) ERK or p38 mediates low-dose BMP-induced cell proliferation. Cells were incubated with low-dose BMP7 with
or without PD98059 (PD) 5 lmol/L or SB203580 (SB) 5 lmol/L (n = 4). VEH, vehicle; *P < 0.05 versus CON; **P < 0.05 versus VEH.
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the expansion of this cell population. Within cap mes-
enchyme also, therefore, there may be a gradient of prolif-
eration depending on the distance from the ureteral tip.
In a similar manner to collecting duct cells and ureteric
bud branching, the effects of BMP7 on cell signaling were
dose dependent (Piscione et al. 1997; Hu et al. 2004). In
murine inner medullary collecting duct (mIMCD) cells,
BMP7 stimulated p38 but not ERK or JNK. In contrast to
metanephric mesenchymal cells, p38 was stimulated and
inhibited by low dose (0.25 nmol/L) and high dose
(10 nmol/L) of BMP7, respectively, in mIMCD cells (Hu
et al. 2004). Furthermore, the time course of cell signaling
was different. In mIMCD cells, p38 was activated at 1 h
after stimulation with BMP7. Most of the previous studies
reporting the activation of MAP kinases, in fact, demon-
strated stimulation at earlier time points. TAK1 or inte-
grin-linked kinase has been shown to mediate the rapid
activation of p38 by BMP7 (Leung-Hagesteijn et al.
2005). In the present study, both p38 and ERK were acti-
vated at 24 h, up to which point most previous studies
had not examined the time course. Gai et al.’s (2009)
study was in accord with our study, which reported acti-
vation of p38 at 48 h with approximately 1 nmol/L
BMP7 in metanephric mesenchymal cells. Delayed activa-
tion of p38 via Smad-dependent pathway by TGF-b has
been reported in pancreatic carcinoma cells (Takekawa
et al. 2002). Similar mechanism may be operative for the
BMP7-induced late activation of p38 or ERK in meta-
nephric mesenchymal cells.
While p38 is activated by higher concentration of
BMP7 than ERK, SB203580 inhibited low-dose BMP7-
induced proliferation in a similar manner to PD98059
suggesting that p38 is also involved in the signaling of
low-dose BMP7. In fact, time course study showed activa-
tion at 24 h by low-dose BMP7 when compared with 0 h.
We think that there was a slight activation of p38, which
Figure 4. Effect of BMP7 on cadherin-11 mRNA expression. (A) BMP7 tended to increase cadherin-11/GAPDH mRNA, assessed by real-time
PCR (n = 2). Expression tended to increase at 0.25 and 1 nmol/L, although there was no statistically significant difference. (B and C) Dose
dependency of BMP7-induced cadherin-11 protein. Cells were incubated with various concentrations of BMP7 and lysed for immunoblot
analysis. A representative immunoblot (B) and quantitative analysis (C, n = 3). *P < 0.05 versus 0 nmol/L. (D and E) ERK and p38 mediate
intermediate-dose BMP7-induced cadherin-11 expression. Cells were incubated with BMP7 1 nmol/L with PD98059 (PD) 5 lmol/L, SB203580
(SB) 5 lmol/L, or both and lysed for immunoblot analysis. A representative immunoblot (D) and quantitative analysis (E, n = 3). VEH, vehicle;
*P < 0.05 versus CON.
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was not detectable by immunoblot and/or obscured by
variability. A previous study reported that BMP7 pro-
moted nephron progenitor cell proliferation through
TAK1, JNK, and a transcription factor Jun (Muthukrish-
nan et al. 2015). In that study, the activation of JNK was
observed at 15 min, and the concentration of BMP7 to
stimulate proliferation and JNK was approximately
3 nmol/L. Whether ERK and p38 are also activated at
later time points and involved in the proliferation of pro-
genitor cells in a similar manner to metanephric mes-
enchymal cells remains unknown.
What are the roles of BMP7 around the tip of ureteric
buds where the concentrations are thought to be higher?
The present study showed that upregulation of CDH11 is
one of them. The siRNA transfection studies demonstrate
that CDH11 is necessary for cap mesenchyme formation.
Cadherin 6 or cadherin E was not induced by BMP7 gen-
erally consistent with previous studies. Thus, WNT sig-
nal-mediated differentiation was not induced by BMP7
even at high concentrations (Brown et al. 2013; Tanigawa
et al. 2016). BMP7 only primes nephron progenitors to
become responsive to WNT signaling toward epithelializa-
tion. Our findings, however, are inconsistent with those
by Gai et al. (2009). They reported that BMP7 of a simi-
lar concentration to our intermediate-dose BMP7 induced
E-cadherin expression through p38 in primary cultured
metanephric mesenchymal cells. While the activation of
p38 is in agreement with our study, CDH11 but not E-
cadherin was induced by BMP7 in MS7. Since they used
primary metanephric mesenchymal cells isolated from
rudiments of rat embryonic day 13.5, it is possible that
the cells were contaminated by ureteric bud cells or con-
tained glomerular epithelial cells. Alternatively, the dis-
crepancy could be due to the difference between primary
cells and immortalized cell line or the antibody used.
CDH11 has been shown to promote cell migration
involved in mesenchymal condensation (Simonneau et al.
1995). In the development of heart and tendon, CDH11-
mediated cell condensation is a prerequisite. In the devel-
oping kidney, it is expressed in metanephric mesenchymal
cells most strongly in those surrounding the ureteric bud
tips (Challen et al. 2004). Recently, CDH11 has been pro-
posed as a regulator of stem cell fate decisions (Alimperti
and Andreadis 2015). More recently, CDH11 has been
shown to localize adherens junctions, which is important
in diverse functions of stem cell biology including the
maintenance and differentiation (Langhe et al. 2016). In
the present study, in the metanephroi cultured with
siRNA for CDH11 for 3 days, cap mesenchyme was
hardly observed. This is reminiscent of the metanephroi
cultured with SB203580 in our previous study, in which
WT1-positive cells were distributed loosely in
Figure 5. Effect of siRNA for cadherin-11 in embryonic day 13 metanephroi. Embryonic day 13 metanephroi were transfected with irrelevant
siRNA, or two different siRNA for CDH11 (a, b) for 24 h, then cultured with 10% DMEM for further 48 h. (A) Metanephroi were stained with
anti-Six2 antibody (green) and pancytokeratin (red). (B) Metanephroi were stained with anti-CDH11 antibody (green) and pancytokeratin (red).
CON, control with no siRNA; Irre, irrelevant siRNA. Scale bars, 250 lm.
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mesenchyme with slight signs of condensation around
ureteric buds (Hida et al. 2002). Furthermore, SB203580-
treated metanephroi were small with reduced glomerular
number. The effect of PD98059 is less severe, and the
metanephros size was maintained and cap mesenchyme,
vesicles, comma-, and S-shaped bodies were observed,
although the number was reduced. These phenotypes may
be due at least in part to the inhibited signaling of BMP7
via p38 or ERK. BMP7 deletion results in hypocellular
kidneys with few nephrons, apoptosis, and accumulation
of loose interstitial mesenchyme similar to the kidneys
treated with SB203580 (Dudley et al. 1995).
Culturing earlier stage metanephroi for 2 days allowed
the measurement of ureteric bud tip number, which was
reduced by siRNA for CDH11. This is considered to be
due to the inhibited signals from cap mesenchyme to
enhance ureteric branching. Decreased metanephros size
may be due to inhibited CDH11 in the stroma and/or
reduced signal from the ureteric bud.
Of interest, CDH11 has been reported to be upregulated
in the embryonic kidney of offspring of rats on low-protein
diet and rats treated with hydrocortisone (Welham et al.
2005; Chan et al. 2010). We have also observed that
maternal nutrient restriction reduced and increased the
expression of CDH11 in the embryonic days 15 and 18 kid-
ney, respectively (M. Awazu, unpubl. obs.). These kidneys
are characterized by reduced nephron number, and CDH11
may be mediating, at least in part, the effect of adverse
intrauterine environment.
The effect of inhibiting ERK or p38 pathway on prolif-
eration and CDH11 upregulation was different. Thus,
proliferation was inhibited by either PD98059 or
SB203580 alone, whereas CDH11 expression was inhibited
by the coincubation with both. In other words, combined
activation of ERK and p38 is needed for cell proliferation,
and isolated activation of either suffices for CDH11
upregulation. While JNK, Smad, and integrin kinase other
than p38 and ERK have been shown to be involved in
proliferative actions of BMP7 (Leung-Hagesteijn et al.
2005; Blank et al. 2009), not much is known regarding
the regulation of CDH11. CDH11 has been reported to
be upregulated by TGF-b1 via ERK in cardiac myofibrob-
lasts (Wang et al. 2014). A transcription factor COUP-
TFII is reported to upregulate CDH11 expression in a
carcinoma cell line and speculated to play a role in the
cadherin-11 to cadherin-6 switch during kidney
Figure 6. Effect of siRNA for cadherin-11 in embryonic day 12 metanephroi. Embryonic day 12 metanephroi were transfected with irrelevant
siRNA or two different siRNA for CDH11 (a, b) for 24 h, then cultured with 10% DMEM for further 24 h. Left column; metanephroi were
stained with anti-Six2 antibody (green) and pancytokeratin (red). Metanephroi cultured with irrelevant siRNA were similar to control (not
shown). Right column: quantitative analysis of ureteric tip number and kidney surface area (n = 3). The number of ureteric bud tips was
counted observing z-stack images. Representative images were selected from one of z-stack images. CON, control with no siRNA; *P < 0.05
versus CON. Scale bars, 250 lm.
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development (Bringuier et al. 2015). Regulatory sequence
of CDH11, however, has not been defined.
Smad proteins are the downstream signaling molecules
of BMP7 and have been shown to function in collecting
duct cells and nephron progenitor cells (Piscione et al.
2001; Brown et al. 2013). They may also be involved in
BMP7-induced proliferation and CDH11 expression in
metanephric mesenchymal cells. All Smads (the receptor-
regulated Smad1, 2, 3, 5, 8, the common partner Smad4,
and inhibitory Smad6, 7) are expressed by mesenchymal
cells in the nephrogenic zone (Simic and Vukicevic 2005).
Of interest, Oxburgh et al. (2004) reported that Smad4
null mesenchyme cells do not aggregate tightly around
the ureteric bud tips in a similar manner to metanephroi
treated with siCDH11. Future studies are needed to
explore the role of Smads as a downstream signaling
molecule of BMP7 in metanephric mesenchymal cells.
In conclusion, we reported the differential functional
roles of BMP7 in metanephric mesenchymal cells, prolifera-
tion, and upregulation of CDH11. Its concentration-depen-
dent function is summarized in Figure 7, which supports
the classic hypothesis that BMP7 acts as a morphogen.
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